http://orcid.org/0000-0003-3050-4595
Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sarah Norton, Anthony P Moll, Jabulile Madi, Nkazi Nkomo, Ralph P Brooks, Laurie Andrews & Sheela V Shenoi. (2023) Community health workers can be trained to identify patients eligible for tuberculosis preventive therapy, but encounter barriers to programme implementation in KwaZulu-Natal, South Africa. African Journal of AIDS Research 22:2, pages 131-135.
Read now
Read now
Divya K. Chandra, Anthony P. Moll, Frederick L. Altice, Elizabeth Didomizio, Laurie Andrews & Sheela V. Shenoi. (2022) Structural barriers to implementing recommended tuberculosis preventive treatment in primary care clinics in rural South Africa. Global Public Health 17:4, pages 555-568.
Read now
Read now
Amiya A. Ahmed, Megan Grammatico, Anthony P. Moll, Sipho Malinga, Philile Makhunga, Salome Charalambous, Joseph B. Ladines-Lim, Justin Jones, Koeun Choi & Sheela V. Shenoi. (2021) Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa. Global Health Action 14:1.
Read now
Read now
Khai Hoan Tram, Florence Mwangwa, Gabriel Chamie, Mucunguzi Atukunda, Asiphas Owaraganise, James Ayieko, Vivek Jain, Tamara D. Clark, Dalsone Kwarisiima, Maya L. Petersen, Moses R. Kamya, Edwin D. Charlebois, Diane V. Havlir, Carina Marquez & the SEARCH collaboration. (2020) Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda. AIDS Care 32:1, pages 119-127.
Read now
Read now
Articles from other publishers (18)
Nyashadzaishe Mafirakureva, Sushant Mukherjee, Boris Tchounga, Daniel Atwine, Boris Tchakounte Youngui, Bob Ssekyanzi, Richard Okello, Simo Leonie, Jennifer Cohn, Martina Casenghi, Anca Vasiliu, Maryline Bonnet & Peter J Dodd. (2023) Household costs incurred under community- and facility-based service-delivery models of tuberculosis preventive therapy for children: a survey in Cameroon and Uganda. Journal of Global Health Reports 7.
Crossref
Crossref
Sheela V. Shenoi, Tassos C. Kyriakides, Emily Kainne Dokubo, Vijayanand Guddera, Peter Vranken, Mitesh Desai, Gerald Friedland & Anthony P. Moll. (2022) Community-based referral for tuberculosis preventive therapy is effective for treatment completion. PLOS Global Public Health 2:12, pages e0001269.
Crossref
Crossref
Renatus Fabiano Nyarubamba, Adam Silumbwe, Choolwe Jacobs, Patricia Maritim, Paschal Mdoe & Joseph Mumba Zulu. (2022) Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania. BMC Infectious Diseases 22:1.
Crossref
Crossref
Dillon T. Wademan, Graeme Hoddinott, Susan E. Purchase, James A. Seddon, Anneke C. Hesseling, Anthony J. Garcia-Prats, Ria Reis & Lindsey J. Reynolds. (2022) Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children. PLOS ONE 17:7, pages e0268560.
Crossref
Crossref
Pia Müller & Luís Velez Lapão. (2022) Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid—Preventive therapies for people living with HIV. PLOS ONE 17:3, pages e0251612.
Crossref
Crossref
Fred C. Semitala, Jillian L. Kadota, Allan Musinguzi, Juliet Nabunje, Fred Welishe, Anne Nakitende, Lydia Akello, Opira Bishop, Devika Patel, Amanda Sammann, Payam Nahid, Robert Belknap, Moses R. Kamya, Margaret A. Handley, Patrick P. J. Phillips, Anne Katahoire, Christopher A. Berger, Noah Kiwanuka, Achilles Katamba, David W. Dowdy & Adithya Cattamanchi. (2021) Completion of isoniazid–rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness–implementation randomized trial. PLOS Medicine 18:12, pages e1003875.
Crossref
Crossref
Fred C. Semitala, Allan Musinguzi, Jackie Ssemata, Fred Welishe, Juliet Nabunje, Jillian L. Kadota, Christopher A. Berger, Achilles Katamba, Noah Kiwanuka, Moses R. Kamya, David Dowdy, Adithya Cattamanchi & Anne R. Katahoire. (2021) Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives. Implementation Science Communications 2:1.
Crossref
Crossref
Courtney M Yuen, Arman Majidulla, Maria Jaswal, Nauman Safdar, Amyn A Malik, Aamir J Khan, Mercedes C Becerra, Salmaan Keshavjee, Chunling Lu & Hamidah Hussain. (2021) Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting. Clinical Infectious Diseases 73:5, pages e1135-e1141.
Crossref
Crossref
Kai Qi Elizabeth Peh, Yu Heng Kwan, Hendra Goh, Hasna Ramchandani, Jie Kie Phang, Zhui Ying Lim, Dionne Hui Fang Loh, Truls Østbye, Dan V. Blalock, Sungwon Yoon, Hayden Barry Bosworth, Lian Leng Low & Julian Thumboo. (2021) An Adaptable Framework for Factors Contributing to Medication Adherence: Results from a Systematic Review of 102 Conceptual Frameworks. Journal of General Internal Medicine 36:9, pages 2784-2795.
Crossref
Crossref
Emmanuella Ngozi Asabor, Elle Lett, Anthony Moll & Sheela V. Shenoi. (2021) “We’ve Got Our Own Beliefs, Attitudes, Myths”: A Mixed Methods Assessment of Rural South African Health Care Workers' Knowledge of and Attitudes Towards PrEP Implementation. AIDS and Behavior 25:8, pages 2517-2532.
Crossref
Crossref
Courtney M. Yuen, Ana Karina Millones, Daniela Puma, Judith Jimenez, Jerome T. Galea, Roger Calderon, Gabriela S. Pages, Meredith B. Brooks, Leonid Lecca, Tom Nicholson, Mercedes C. Becerra & Salmaan Keshavjee. (2021) Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru. PLOS ONE 16:2, pages e0247411.
Crossref
Crossref
Clay Roscoe, Chris Lockhart, Michael de Klerk, Andrew Baughman, Simon Agolory, Michael Gawanab, Heather Menzies, Anna Jonas, Natanael Salomo, Negussie Taffa, David Lowrance, Katherine Robsky, Deanna Tollefson, Eric Pevzner, Ndapewa Hamunime, Farai Mavhunga & Helena Mungunda. (2020) Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis. BMC Public Health 20:1.
Crossref
Crossref
Richardson Augusto Rosendo da Silva, Wenysson Noleto dos Santos, Francisca Marta de Lima Costa Souza, Rebecca Stefany da Costa Santos, Izaque Cavalcanti de Oliveira, Hallyson Leno Lucas da Silva & Dhyanine Morais de Lima. (2020) Controle ineficaz da saúde em pessoas vivendo com AIDS: análise de conteúdo. Acta Paulista de Enfermagem 33.
Crossref
Crossref
Brooke A. Jarrett, Daniel M. Woznica, Carla Tilchin, Nthabiseng Mpungose, Katlego Motlhaoleng, Jonathan E. Golub, Neil A. Martinson & Colleen F. Hanrahan. (2019) Promoting Tuberculosis Preventive Therapy for People Living with HIV in South Africa: Interventions Hindered by Complicated Clinical Guidelines and Imbalanced Patient-Provider Dynamics. AIDS and Behavior 24:4, pages 1106-1117.
Crossref
Crossref
Eltony Mugomeri, Dedré Olivier & Wilhelmiena M.J. van den Heever. (2019) Tracking the rate of initiation and retention on isoniazid preventive therapy in a high human immunodeficiency virus and tuberculosis burden setting of Lesotho. Southern African Journal of Infectious Diseases 34:1.
Crossref
Crossref
Saziso Nyathi, Riitta A. Dlodlo, Srinath Satyanarayana, Kudakwashe C. Takarinda, Hannock Tweya, Sithokozile Hove, Ronnie Matambo, Winnie Mandewo, Khulamuzi Nyathi, Edwin Sibanda & Anthony D. Harries. (2019) Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe. PLOS ONE 14:10, pages e0223076.
Crossref
Crossref
Andrea DeLuca, Gauri Dhumal, Mandar Paradkar, Nishi Suryavanshi, Vidya Mave, Rewa Kohli, Shri Vijay Bala Yogendra Shivakumar, Vidula Hulyolkar, Archana Gaikwad, Ashwini Nangude, Geeta Pardeshi, Dileep Kadam & Amita Gupta. (2018) Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: a vital part of elimination. BMC Infectious Diseases 18:1.
Crossref
Crossref
Khai Hoan Tram, Florence Mwangwa, Mucunguzi Atukunda, Asiphas Owaraganise, James Ayieko, Albert Plenty, Dalsone Kwariisima, Tamara D. Clark, Maya L. Petersen, Edwin D. Charlebois, Moses R. Kamya, Gabriel Chamie, Diane V. Havlir & Carina Marquez. (2017) Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care. JAIDS Journal of Acquired Immune Deficiency Syndromes 76:5, pages e115-e117.
Crossref
Crossref